Vaccine against hepatitis B — 18 months prevention in a high risk setting
- 1 November 1978
- journal article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 166 (1-4) , 109-118
- https://doi.org/10.1007/bf02121140
Abstract
The development of a vaccine against hepatitis B prepared with purified and inactivated HBs Ag is described. This vaccine has been applied in patients and staff members of haemodialysis centres. Safety and efficiency of the vaccine are very satisfactory. The response of patients to immunisation was significantly lower compared to the response of the staff members. None of the volunteers who had a primary response to immunisation developed signs of clinical or biological hepatitis.Keywords
This publication has 22 references indexed in Scilit:
- Hepatitis B Vaccine: Efficacy in High-Risk Settings, a Two-Year StudyIntervirology, 1978
- IMMUNISATION AGAINST HEPATITIS B IN MANThe Lancet, 1976
- A case/control study of the association between primary liver cancer and hepatitis b infection in senegalInternational Journal of Cancer, 1975
- Hepatitis B subunit vaccineThe Lancet Healthy Longevity, 1975
- Purified and inactivated human hepatitis B vaccineThe Lancet Healthy Longevity, 1975
- Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staffThe Lancet Healthy Longevity, 1975
- Attempt to prevent hepatitis by using specific anti-HBs immunoglobulinThe Lancet Healthy Longevity, 1975
- The Purification of Hepatitis‐Associated Antigen (HAA/SH/AU) from Human Serum and the Preparation of a Sheep Anti‐HAA SerumVox Sanguinis, 1972
- Chemical Coupling of Peptides and Proteins to Polysaccharides by Means of Cyanogen HalidesNature, 1967
- The fractionation of protein mixtures by linear polymers of high molecular weightBiochimica et Biophysica Acta (BBA) - General Subjects, 1964